Table 14.
Individual animal clinical signs data at phase I.
| Experimental Day |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Day 1 |
Day 2 |
Day 3 |
|||||||||
| Pre dose |
Post dose |
Pre dose |
Post dose |
Pre-Necropsy |
|||||||
| Group No. | A # | M | F | M | F | M | F | M | F | M | F |
| G1 | 1 | N | N | N | N | N | N | N | N | N | N |
| 2 | N | N | N | N | N | N | N | N | N | N | |
| 3 | N | N | N | N | N | N | N | N | N | N | |
| G2 | 4 | N | N | N | N | N | N | N | N | N | N |
| 5 | N | N | N | N | N | N | N | N | N | N | |
| 6 | N | N | N | N | N | N | N | N | N | N | |
| G3 | 7 | N | N | N | N | N | N | N | N | N | N |
| 8 | N | N | N | N | N | N | N | N | N | N | |
| 9 | N | N | N | N | N | N | N | N | N | N | |
| G4 | 10 | N | N | N | N | N | N | N | N | N | N |
| 11 | N | N | N | N | N | N | N | N | N | N | |
| 12 | N | N | N | N | N | N | N | N | N | N | |
| G5 | 13 | N | N | N | N | N | N | N | N | N | N |
| 14 | N | N | N | N | N | N | N | N | N | N | |
| 15 | N | N | N | N | N | N | N | N | N | N | |
A#= Animal number; N= Normal; M= Male; F= Female